家族性腺瘤性息肉病（FAP）化学预防的现状 - Suppr

Suppr

超能文献

The current status of chemoprevention in FAP.

作者信息

Wallace M H, Lynch P M

机构信息

Department of Surgery, Watford General Hospital, Vicarage Road, WD18 0DH, Watford, UK.

出版信息

Fam Cancer. 2006;5(3):289-94; discussion 295-6. doi: 10.1007/s10689-005-5676-0.

DOI:10.1007/s10689-005-5676-0

PMID:16998675

Abstract

摘要

相似文献

The current status of chemoprevention in FAP.家族性腺瘤性息肉病（FAP）化学预防的现状

Fam Cancer. 2006;5(3):289-94; discussion 295-6. doi: 10.1007/s10689-005-5676-0.

Chemoprevention of FAP with sulindac.舒林酸对家族性腺瘤性息肉病的化学预防作用。

Curr Oncol Rep. 2002 Nov;4(6):463. doi: 10.1007/s11912-002-0061-8.

Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.依氟鸟氨酸（CPP-1X）/舒林酸联合疗法与单药疗法治疗家族性腺瘤性息肉病（FAP）患者的疗效和安全性：一项随机、双盲、III期试验的设计与原理

BMC Gastroenterol. 2016 Aug 2;16(1):87. doi: 10.1186/s12876-016-0494-4.

Assessing barriers to a rational chemoprevention trial design in young patients with familial adenomatous polyposis.评估年轻家族性腺瘤性息肉病患者合理化学预防试验设计的障碍。

Eur J Cancer Prev. 2017 Jul;26(4):277-284. doi: 10.1097/CEJ.0000000000000256.

[Familial adenomatous polyposis (FAP)--diagnosis and management].[家族性腺瘤性息肉病（FAP）——诊断与管理]

Gan To Kagaku Ryoho. 2002 Apr;29(4):532-8.

Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.人黄素单加氧酶3基因多态性在舒林酸介导的家族性腺瘤性息肉病一级化学预防中的作用

Clin Cancer Res. 2004 Dec 15;10(24):8357-62. doi: 10.1158/1078-0432.CCR-04-1073.

Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.舒林酸与厄洛替尼对比安慰剂对家族性腺瘤性息肉病十二指肠肿瘤的影响：一项随机临床试验

JAMA. 2016;315(12):1266-75. doi: 10.1001/jama.2016.2522.

Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.舒林酸可抑制遗传性非息肉病性结直肠癌和家族性腺瘤性息肉病患者正常外观结肠中的β-连环蛋白表达。

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1608-12. doi: 10.1158/1055-9965.EPI-05-0112.

Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.在一项针对家族性腺瘤性息肉病患者的塞来昔布安慰剂对照试验中，细胞增殖和凋亡指数可预测腺瘤消退情况。

Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):920-7.

Sulindac and Erlotinib for Familial Adenomatous Polyposis.舒林酸与厄洛替尼治疗家族性腺瘤性息肉病

JAMA. 2016 Aug 2;316(5):544-5. doi: 10.1001/jama.2016.7592.

引用本文的文献

Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?结直肠癌化学预防：这会是结直肠癌预防的未来方向吗？

ScientificWorldJournal. 2012;2012:327341. doi: 10.1100/2012/327341. Epub 2012 Apr 29.

An intermittent approach for cancer chemoprevention.间歇性癌症化学预防方法。

Nat Rev Cancer. 2011 Nov 10;11(12):879-85. doi: 10.1038/nrc3167.

Chemoprevention with special reference to inherited colorectal cancer.化学预防，特别涉及遗传性结直肠癌

Fam Cancer. 2008;7(1):59-64. doi: 10.1007/s10689-007-9158-4. Epub 2007 Aug 7.

本文引用的文献

Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.前列腺素、鸟氨酸脱羧酶和多胺在家族性腺瘤性息肉病的一级化学预防中的作用

Gastroenterology. 2004 Feb;126(2):425-31. doi: 10.1053/j.gastro.2003.11.013.

Rofecoxib reduces polyp recurrence in familial polyposis.罗非昔布可降低家族性腺瘤性息肉病患者息肉的复发率。

Dig Dis Sci. 2003 Oct;48(10):1998-2002. doi: 10.1023/a:1026130623186.

A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.一项关于选择性环氧化酶-2抑制剂罗非昔布对家族性腺瘤性息肉病患者直肠息肉影响的随机、双盲、安慰剂对照试验。

Clin Cancer Res. 2003 Oct 15;9(13):4756-60.

Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study.抗性淀粉和/或阿司匹林能否预防结肠肿瘤的发生？息肉预防协同行动（CAPP）1研究。

Proc Nutr Soc. 2003 Feb;62(1):51-7. doi: 10.1079/PNS2002236.

Peroral sustained-release indomethacin treatment for rectal adenomas in familial adenomatous polyposis: a pilot study.

Hepatogastroenterology. 2002 Sep-Oct;49(47):1259-61.

Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive.

J Gastrointest Surg. 2002 Jul-Aug;6(4):563-8. doi: 10.1016/s1091-255x(01)00042-7.

Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.姜黄素在家族性腺瘤性息肉病模型min/+小鼠中的化学预防功效及药代动力学

Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):535-40.

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.一项关于选择性环氧化酶2抑制剂塞来昔布治疗家族性腺瘤性息肉病十二指肠息肉病的随机、双盲、安慰剂对照研究。

Gut. 2002 Jun;50(6):857-60. doi: 10.1136/gut.50.6.857.

Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.舒林酸用于家族性腺瘤性息肉病的长期治疗：一项前瞻性队列研究。

Gastroenterology. 2002 Mar;122(3):641-5. doi: 10.1053/gast.2002.31890.

Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis.家族性腺瘤性息肉病患者结肠和直肠中APC基因型、息肉分布与口服舒林酸治疗之间的关系

Dis Colon Rectum. 2001 Aug;44(8):1090-7; discussion 1097-9. doi: 10.1007/BF02234627.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验